The clinical evidence gap is enormous
These effects are likely primarily mediated through actions in various regions of the brain involved in the regulation of appetite and food intake [18], as supported by preclinical studies [19,20,21,22], multiple human imaging studies [18], and the GLP-1R expression patterns in the human brain [9, 23]
no serious drug-related events in pivotal studies
#Obesity #Type2Diabetes #GLP1 #ClinicalTrials #Phase3 #Biotech #Pharma #DrugDevelopment #HealthcareInnovation #LifeSciences #MetabolicHealth #PharmaceuticalIndustry To view or add a comment, sign in More Relevant Posts The most powerful weight loss drug ever tested is heading to the FDA, and it just complicated its own biggest selling point
The GLP-1 Exit Strategy The proper way to use GLP-1 GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are the fastest-selling class of drugs in the history of medicine